DB2115 (tertahydrochloride)
Product Specifications
UNSPSC Description
DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for researching cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
Target Antigen
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/db2115-tertahydrochloride.html
Purity
99.13
Solubility
DMSO : 15.85 mg/mL (ultrasonic;warming;adjust pH to 4 with HCl;heat to 60°C)
Smiles
N=C(C1=CC=C2N=C(C3=CC=C(OCCCCOC4=CC=C(C5=NC6=CC=C(C(N)=N)C=C6N5)C=C4)C=C3)NC2=C1)N.[H]Cl.[H]Cl.[H]Cl.[H]Cl
Molecular Weight
704.48
References & Citations
[1]W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-124676A/DB2115-tertahydrochloride-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-124676A/DB2115-tertahydrochloride-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1366126-19-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
